News
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as ...
The trade war between China and the US is entering the next round and reaching a new peak. The Middle Kingdom is restricting ...
The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...
Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant reported better-than ...
BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...
14h
MedPage Today on MSNDid FDA Pick the Wrong COVID Vaccine Strain Last Season?The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
ORLANDO, Fla. – It’s going to be another hot and sticky day across Central Florida as a weak front remains stationary over ...
While many of us may think of the cold and flu viruses as a fall or winter nuisance, summer colds are actually quite common.
EU Commission deleted important text messages between von der Leyen and Pfizer CEO Bourla from vaccine negotiations. Chief of ...
The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...
Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results